Author

J. Florido

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Lopez-Rodriguez· 2 shared F. Oppel· 2 shared G. Escames· 2 shared H. Sudhoff· 2 shared L. Martinez-Ruiz· 2 shared A. Guerra-Librero· 1 shared A. Ten-Esteve· 1 shared B. I. Fernandez-Gil· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Lopez-Rodriguez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress

L. Martinez-Ruiz, J. Florido, C. Rodriguez-Santana, A. Lopez-Rodriguez, A. Guerra-Librero, B. I. Fernandez-Gil, P. Garcia-Tarraga, J. M. Garcia-Verdugo, F. Oppel, H. Sudhoff, D. Sanchez-Porras, A. Ten-Esteve, J. Fernandez-Martinez, P. Gonzalez-Garcia, I. Rusanova, , G. Escames

This study shows that intratumoral melatonin injection enhances tumor regression in head and neck cancer models by increasing mitochondrial oxidative stress and improving cisplatin efficacy.

bioRxiv · Jul 17, 2023Cancer Biology

Inducible mucosa-like differentiation of head and neck cancer cells drives the epigenetically determined loss of cell malignancy

F. Oppel, S. Gendreizig, L. Martinez-Ruiz, J. Florido, A. Lopez-Rodriguez, H. Pabla, L. Loganathan, L. Hose, P. Kuehnel, P. Schmidt, M. Schuermann, J. M. Neumann, F. Viyof Ful, L. U. Scholtz, D. Ligum, , H. Sudhoff

This study shows that HNSCC cells can differentiate into non-malignant cells, losing their tumor-initiating potential and expressing KRT17, suggesting differentiation as a therapeutic target.

bioRxiv · Jun 30, 2023 · PreprintCancer Biology